Microglial NF-κB activation contributes to the pathogenesis of Alzheimer’s disease via the accumulation of senile plaques (Wang C. et al., 2022) and major depressive disorder (Wang H. et al., 2022). The gene discussed is NFKB1; the disease is early-onset autosomal dominant Alzheimer disease.